Results 71 to 80 of about 2,649 (175)
Indian Journal of Ophthalmology, 2018 Purpose: The purpose of this study is to detect the optic nerve head (ONH) and peripapillary perfusion in eyes with acute nonarteritic anterior ischemic optic neuropathy (NAION) compared to the fellow normal eyes using optical coherence tomography ...
Uppal Gandhi +6 more
doaj +1 more source
, 2023 The QRK207 study was the first multi-country treatment trial for patients with acute nonarteritic anterior ischemic optic neuropathy (NAION). We assessed ophthalmic and systemic factors associated with an increased risk of NAION and examined if they ...
Neil Miller; Nathalie Jette; Rachelle Morgenstern; Parul Agarwal; Leonard Levin; Mark Kupersmith
core +2 more sources
Hypoperfusion states could increase the risk of non-arteritic anterior ischemic optic neuropathy.
PLoS ONEBackgroundNon-arteritic anterior ischemic optic neuropathy (NAION) is a leading cause of acute optic nerve damage. While cardiovascular risk factors such as hypertension, diabetes mellitus, and obstructive sleep apnea are well-established, the ...
Jasmin Gabbay +7 more
doaj +1 more source
A case of non-arteritic anterior ischemic optic neuropathy after completion of Harvoni therapy
American Journal of Ophthalmology Case Reports, 2017 Purpose: To report the first reported case of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of Harvoni (Gilead Sciences, Foster City, CA, USA), a newly approved treatment for Hepatitis C.
Niranjan Manoharan, MD +1 more
doaj +1 more source
Pituitary Adenoma Masquerading as NAION
, 2023 Patient 62-year-old male presented with vision loss in the left eye diagnosed with NAION then vision continue to get worse in both eye MRI of the brain showed pituitary ...
Nagham Al-Zubidi, MD
core
Journal of Ophthalmology, 2014 Purpose. To measure central corneal thickness (CCT) in patients with history of nonarteritic anterior ischemic optic neuropathy (NAION). Patients and Methods.
Haneen Jabaly-Habib +2 more
doaj +1 more source
, 2019 Summary: CRAO/NAION: 1. Risk factors for both 2. Presentation a. Patient has vasculopathic factors i. Hypertension ii. Diabetes iii. Hyperlipidemia iv. Smoker b. Acute unilateral vision loss c.
Andrew G. Lee, MD; Akash Gupta
core
Indian Journal of OphthalmologyPurpose: To assess optical coherence tomography angiography (OCTA) changes in acute nonarteritic anterior ischemic optic neuropathy (NAION) eyes compared to fellow unaffected eyes and describe the longitudinal OCTA changes within the first 12 weeks of ...
Omar M Said +3 more
doaj +1 more source
Presentation of NAION in a Global Treatment Trial
, 2019 Knowledge of presenting features and systemic factors associated with acute NAION is based predominantly on retrospective reports and one prospective treatment trial, with only 258 participants.
Mark J. Kupersmith
core +1 more source
Mile High Observations of Altitude in NAION
, 2023 High altitude has been suggested in the literature as a potential risk factor for non-arteritic anterior ischemic optic neuropathy (NAION) secondary to hypoxia, with insufficient data available to substantiate this ...
Devon A. Cohen, MD
core